Document is current
Any future updates will be listed below
-
Authors
Berthelot, William https://orcid.org/0009-0001-7304-670X
Sirois, Caroline https://orcid.org/0000-0003-3294-7883
Julien, Anne-Sophie
Amiable, Nathalie
Bessette, Louis https://orcid.org/0000-0002-6834-2731
Desaulniers, Philippe
Audet, Marie-Claude
Lagacé, Sonia
Fortin, Paul R. https://orcid.org/0000-0002-7278-2596
-
Funding
Funding for this research was provided by:
Centre Hospitalier Universitaire de Québec (Centre Hospitalier Universitaire de Québec)
- License Information
-
More Information
Article History
Received: 13 December 2024
Accepted: 1 February 2025
First Online: 8 February 2025
Declarations
:
: The authors declare no conflicts of interest.
: This article was written without the use of artificial intelligence and has not been reviewed by a commercial editing service.
: An earlier version of the abstract before final analysis was presented at the Canadian Rheumatology Association 2023 Annual Scientific Meeting: Berthelot W, Sirois C, Julien AS, Amiable N, Fortin PR (2023) Polypharmacy in Systemic Autoimmune Rheumatic Diseases. Canadian Rheumatology Association Meeting Quebec City Convention Centre Quebec City, Quebec, Canada February 8–11, 2023. J Rheumatol 50(7 Suppl 1):7-100. .
